De La Cruz Sulfur Acne Medication
NDC Package 24286-1525-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

De La Cruz Sulfur Acne Medication is a . Marketed by Dlc Laboratories, Inc., this product is identified by NDC 24286-1525 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
24286-1525-2
Package Description
73.7 g in 1 JAR
Product Code
24286-1525
11-Digit Billing Format
24286152502

Clinical Specifications

Proprietary Name
De La Cruz Sulfur Acne Medication
Dosage Form
-

Regulatory & Marketing

Labeler Name
Dlc Laboratories, Inc.
FDA Application #
M006
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-11-2014
End Marketing Date
01-01-2024
Listing Expiration
01-01-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (24286-1525). Click a package code to view its specific billing and regulatory data.

24286-1525-3
2.8 g in 1 POUCH
24286-1525-4
6 g in 1 JAR

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24286-1525-2 identifies a specific commercial package of 73.7 g in 1 jar of De La Cruz Sulfur Acne Medication, labeled by Dlc Laboratories, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dlc Laboratories, Inc. on August 11, 2014. The current certification is valid through January 01, 2024.

How is this Dlc Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24286152502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
24286-1525-2
11-Digit CMS (5-4-2)
24286-1525-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.